Blog

Story About UVA Essential Tremor Trial Airing on TV Stations Around the US

Published:
TV viewers in dozens of American cities are learning about the FUSF-funded essential tremor trial at the University of Virginia. In early August, Ivanhoe Broadcast News — a syndication service that works in partnership with the American Institute of Physics — provided subscribing stations with a video report about the trial. Stations will air the story whenever newscast time permits. The story features interviews with the study’s first patient, Billy R. Williams, and its principal investigator, W. Jeffrey Elias, MD.
Read More ...

FUSF Among Sponsors and Faculty of Rome Symposium

Published:
Abstract submissions were set to close last week for the 1st European Symposium on MR-guided Focused Ultrasound Therapy. Organized by the Department of Radiology of the University of Rome La Sapienza, the symposium will be held September 22 and 23, 2011 in Rome.
Read More ...

Baltimore Sun Article Asserts that Celsion’s Move to NJ is Driven by Lack of Talent in MD

Published:
Celsion Corporation recently announced it is moving its headquarters from Columbia, MD to Princeton, NJ. An article published in yesterday’s Baltimore Sun asserts that the move is prompted by the lack of a labor pool in Maryland with experience in marketing, selling and distributing pharmaceuticals. In addition to sponsoring clinical trials that are assessing its heat-sensitive drug, Thermodox, as a treatment for liver and breast cancer, Celsion is working in partnership with Philips Healthcare to develop a new focal drug delivery treatment for metastatic bone cancer. The method combines  ThermoDox with Philips’ MR-guided focused ultrasound technology.
Read More ...

FUSF Research Award Applications Reach Record Levels

Published:
The FUS Foundation’s Research Awards Program received a record number of applications during the first half of 2011. By the end of the second quarter, the Foundation had received 15 proposals, eclipsing the whole-year totals of 11 and 14 for 2009 and 2010, respectively. “It’s incredibly exciting news for the Foundation,” says Hannah Edelen, Director of Research and Fellowship Programs. Edelen attributes the rise to the Foundation’s change from a rolling acceptance policy to a quarterly deadline system that encourages researchers to submit proposals sooner.
Read More ...
InSightec Provides Update on its Prostate Cancer Clinical Trial Russian FUS Center Nearing 900-patient Mark in Treating Uterine Fibroids Virginia Newspaper Highlights the Foundation and MRgFUS Company That Pioneered Therapeutic Ultrasound is Collaborating with Siemens to Develop an MR-guided Treatment System Johns Hopkins Study Finds MR-guided Focused Ultrasound Offers Long-term Benefit to Uterine Fibroid Patients